News
10-05-2023, 01:58 PM
Researchers at Vanderbilt-Ingram Cancer Center have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
More... (https://www.news-medical.net/news/20231005/Researchers-discover-a-vulnerability-in-immunotherapy-resistant-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20231005/Researchers-discover-a-vulnerability-in-immunotherapy-resistant-triple-negative-breast-cancer.aspx)